Clinical Trials in Arizona

Showing 10821-10840 of 14,395 trials

Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy

NCT01932502

The purpose of the study is to examine the clinical safety, tolerability, and efficacy of clobazam (Onfi) when it replaces the pre-existing clonazepam therapy in patients with refractory epilepsy.

Refractory Epilepsy

St. Joseph's Hospital and Medical Center, Phoenix21 participantsStarted Feb 2013

Phoenix, Arizona, United States

COMPLETEDPhase 242 miles

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

NCT01436500

A study of ifetroban in the treatment of hepatorenal syndrome (HRS) in hospitalized adult patients to assess the safety and pharmacokinetics of 3 days of intravenous ifetroban.

Hepatorenal Syndrome

Cumberland Pharmaceuticals55 participantsStarted Oct 2011

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +9 more locations

Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Find Trials by Condition in Arizona

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

A Novel Method to Determine HIV Incidence Among Youth

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

C2P Mobilization Intervention (Pilot)

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

YouScript IMPACT Registry

Treatment De-Intensification and Residual HIV-1 in Youth

CDC-ATN Linkage Evaluation

HIV Treatment-Readiness Measure (HTRM) Validation

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Linkage to Care - Part II

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Immunologic Memory (Supp. of ATN 024)

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

EPO906 in Carcinoid and Other Neuroendocrine Tumors